Care to Quit: a stepped wedge cluster randomised controlled trial to implement best practice smoking cessation care in cancer centres.
Cancer
Implementation
Quitline
Smoking
Smoking cessation
Journal
Implementation science : IS
ISSN: 1748-5908
Titre abrégé: Implement Sci
Pays: England
ID NLM: 101258411
Informations de publication
Date de publication:
04 03 2021
04 03 2021
Historique:
received:
09
12
2020
accepted:
18
02
2021
entrez:
5
3
2021
pubmed:
6
3
2021
medline:
26
10
2021
Statut:
epublish
Résumé
Cigarette smoking in people with cancer is associated with negative treatment-related outcomes including increased treatment toxicity and complications, medication side effects, decreased performance status and morbidity. Evidence-based smoking cessation care is not routinely provided to patients with cancer. The purpose of this study is to determine the effectiveness of a smoking cessation implementation intervention on abstinence from smoking in people diagnosed with cancer. A stepped wedge cluster randomised design will be used. All sites begin in the control condition providing treatment as usual. In a randomly generated order, sites will move to the intervention condition. Based on the Theoretical Domains Framework, implementation of Care to Quit will include (i) building the capability and motivation of a critical mass of key clinical staff and identifying champions; and (ii) identifying and implementing cessation care models/pathways. Two thousand one hundred sixty patients with cancer (diagnosed in the prior six months), aged 18+, who report recent combustible tobacco use (past 90 days or in the 30 days prior to cancer diagnosis) and are accessing anti-cancer therapy, will be recruited at nine sites. Assessments will be conducted at baseline and 7-month follow-up. The primary outcome will be 6-month abstinence from smoking. Secondary outcomes include biochemical verification of abstinence from smoking, duration of quit attempts, tobacco consumption, nicotine dependence, provision and receipt of smoking cessation care, mental health and quality of life and cost effectiveness of the intervention. This study will implement best practice smoking cessation care in cancer centres and has the potential for wide dissemination. The trial is registered with ANZCTR (www.anzctr.org.au): ACTRN ( ACTRN12621000154808 ) prior to the accrual of the first participant and will be updated regularly as per registry guidelines.
Sections du résumé
BACKGROUND
Cigarette smoking in people with cancer is associated with negative treatment-related outcomes including increased treatment toxicity and complications, medication side effects, decreased performance status and morbidity. Evidence-based smoking cessation care is not routinely provided to patients with cancer. The purpose of this study is to determine the effectiveness of a smoking cessation implementation intervention on abstinence from smoking in people diagnosed with cancer.
METHODS
A stepped wedge cluster randomised design will be used. All sites begin in the control condition providing treatment as usual. In a randomly generated order, sites will move to the intervention condition. Based on the Theoretical Domains Framework, implementation of Care to Quit will include (i) building the capability and motivation of a critical mass of key clinical staff and identifying champions; and (ii) identifying and implementing cessation care models/pathways. Two thousand one hundred sixty patients with cancer (diagnosed in the prior six months), aged 18+, who report recent combustible tobacco use (past 90 days or in the 30 days prior to cancer diagnosis) and are accessing anti-cancer therapy, will be recruited at nine sites. Assessments will be conducted at baseline and 7-month follow-up. The primary outcome will be 6-month abstinence from smoking. Secondary outcomes include biochemical verification of abstinence from smoking, duration of quit attempts, tobacco consumption, nicotine dependence, provision and receipt of smoking cessation care, mental health and quality of life and cost effectiveness of the intervention.
DISCUSSION
This study will implement best practice smoking cessation care in cancer centres and has the potential for wide dissemination.
TRIAL REGISTRATION
The trial is registered with ANZCTR (www.anzctr.org.au): ACTRN ( ACTRN12621000154808 ) prior to the accrual of the first participant and will be updated regularly as per registry guidelines.
Identifiants
pubmed: 33663518
doi: 10.1186/s13012-021-01092-5
pii: 10.1186/s13012-021-01092-5
pmc: PMC7934502
doi:
Banques de données
ANZCTR
['ACTRN12621000154808']
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
23Références
Arch Intern Med. 1998 Sep 14;158(16):1789-95
pubmed: 9738608
BMJ. 2014 Feb 13;348:g1151
pubmed: 24524926
Expert Rev Respir Med. 2010 Jun;4(3):291-9
pubmed: 20524911
Chest. 2006 Dec;130(6):1784-90
pubmed: 17166997
Addiction. 2012 Jun;107(6):1066-73
pubmed: 22175545
Int J Cancer. 2013 Jan 15;132(2):401-10
pubmed: 22539012
Adm Policy Ment Health. 2011 Mar;38(2):65-76
pubmed: 20957426
Pharmacoeconomics. 2007;25(5):365-84
pubmed: 17488136
Cochrane Database Syst Rev. 2019 May 02;5:CD002850
pubmed: 31045250
Cochrane Database Syst Rev. 2009 Apr 15;(2):CD003030
pubmed: 19370580
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Bone Marrow Transplant. 2011 Feb;46(2):285-90
pubmed: 20479707
Cochrane Database Syst Rev. 2007 Oct 17;(4):CD000409
pubmed: 17943742
Healthc Q. 2009;12 Spec No Patient:123-8
pubmed: 19667789
Cochrane Database Syst Rev. 2003;(3):CD000259
pubmed: 12917891
PLoS One. 2018 Jul 30;13(7):e0201552
pubmed: 30059534
J Natl Compr Canc Netw. 2015 May;13(5 Suppl):643-5
pubmed: 25995418
Asia Pac J Clin Oncol. 2018 Dec;14(6):431-438
pubmed: 29706029
Ann Thorac Surg. 2009 Aug;88(2):362-70; discussion 370-1
pubmed: 19632374
Breast Cancer Res Treat. 2010 Jun;121(3):627-34
pubmed: 20424909
Eur J Cancer Care (Engl). 2017 Jan;26(1):
pubmed: 26423576
Thorax. 2000 Dec;55(12):987-99
pubmed: 11083883
Psychosomatics. 2009 Nov-Dec;50(6):613-21
pubmed: 19996233
Nicotine Tob Res. 2010 Oct;12 Suppl:S4-11
pubmed: 20889479
Contemp Clin Trials. 2007 Feb;28(2):182-91
pubmed: 16829207
Nicotine Tob Res. 2020 Jun 12;22(7):1098-1106
pubmed: 31271211
Oncology. 2010;78(5-6):289-301
pubmed: 20699622
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
J Am Coll Surg. 2009 Nov;209(5):557-64
pubmed: 19854394
Cancer. 2014 Jul 1;120(13):1914-6
pubmed: 24687615
J Oncol Pract. 2013 Sep;9(5):258-62
pubmed: 23943904
BMC Public Health. 2006 Dec 11;6:300
pubmed: 17156479
Eur J Surg Oncol. 2002 Dec;28(8):815-20
pubmed: 12477471
Otolaryngol Head Neck Surg. 2013 Aug;149(2):200-11
pubmed: 23715685
Tob Control. 2003 Mar;12(1):60-6
pubmed: 12612364
Addict Behav. 2017 Jan;64:13-20
pubmed: 27533077
CA Cancer J Clin. 2014 Jul-Aug;64(4):272-90
pubmed: 24817674
Ann Surg Oncol. 2011 May;18(5):1460-8
pubmed: 21184193
SAGE Open Med. 2018 May 17;6:2050312118773261
pubmed: 29796266
J Public Health (Oxf). 2007 Dec;29(4):338-42
pubmed: 17998258
BMJ. 2015 Feb 06;350:h391
pubmed: 25662947
Int J Radiat Oncol Biol Phys. 1998 Sep 1;42(2):247-55
pubmed: 9788401
Cancer. 2014 Feb 15;120(4):562-9
pubmed: 24496870
Transl Lung Cancer Res. 2019 May;8(Suppl 1):S11-S20
pubmed: 31211102
Cochrane Database Syst Rev. 2001;(2):CD003030
pubmed: 11406063
Nicotine Tob Res. 2010 Oct;12 Suppl:S45-50
pubmed: 20889480
Drug Alcohol Depend. 2013 Feb 1;128(1-2):15-9
pubmed: 22943961
Menopause. 2006 May-Jun;13(3):423-33
pubmed: 16735939
Br J Addict. 1989 Jul;84(7):791-9
pubmed: 2758152
Radiother Oncol. 2012 Apr;103(1):45-8
pubmed: 22119370
Implement Sci. 2012 Apr 24;7:37
pubmed: 22530986
Worldviews Evid Based Nurs. 2010 Dec;7(4):238-51
pubmed: 20880009
Head Neck. 2007 Dec;29(12):1090-101
pubmed: 17563889
Ann Oncol. 2013 Apr;24(4):1073-8
pubmed: 23136235
J Thorac Oncol. 2015 Nov;10(11):1532-7
pubmed: 26317914
J Gastrointest Surg. 2011 Feb;15(2):250-9, discussion 259-61
pubmed: 21161427
Cancer. 2009 Oct 1;115(19):4636-44
pubmed: 19569250
Cochrane Database Syst Rev. 2012 Jun 13;(6):CD000259
pubmed: 22696318
JAMA. 1990 Jan 26;263(4):549-56
pubmed: 2104640
Addict Behav. 2009 Apr;34(4):365-73
pubmed: 19097706
Cochrane Database Syst Rev. 2013 May 31;(5):CD000165
pubmed: 23728631
J Thorac Oncol. 2013 May;8(5):543-8
pubmed: 23529191
Int J Radiat Oncol Biol Phys. 2009 Jan 1;73(1):166-72
pubmed: 18805649